Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
Conditions:   Advanced Malignant Solid Neoplasm;   Hematopoietic and Lymphoid Cell Neoplasm Interventions:   Drug: Olanzapine;   Drug: Placebo Administration;   Other: Questionnaire Administration Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
Conditions:   Advanced Malignant Solid Neoplasm;   Hematopoietic and Lymphoid Cell Neoplasm Interventions:   Drug: Olanzapine;   Drug: Placebo Administration;   Other: Questionnaire Administration Sponsors:   Mayo Clinic;   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials